IDENTIFICATION OF 15-DEOXY--PROSTAMIDE J MOLECULAR TARGETS IN B16F10 MURINE MELANOMA CELLS

Therapeutic benefits of the endocannabinoid metabolite 15dPMJ₂ as a monotherapy and in combination with immune checkpoint inhibitors

IDENTIFICATION OF 15-12,14 DEOXY--PROSTAMIDE J MOLECULAR TARGETS IN B16F10 MURINE MELANOMA CELLS